| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACE gene I/D polymorphism in type 2 diabetes: the Gujarat population
|
Dwivedi, Mitesh
|
|
2011
|
|
3 |
p. 153-154
|
artikel
|
| 2 |
ADA-EASD diabetes guidance: individualised treatment of hyperglycaemia
|
Day, Caroline
|
|
2012
|
|
3 |
p. 146-151
|
artikel
|
| 3 |
Amylin analogue as an antidiabetic agent
|
Day, Caroline
|
|
2005
|
|
3 |
p. 151-154
|
artikel
|
| 4 |
An unusual case of blackouts in insulin-treated diabetes mellitus
|
Maclean, Peter
|
|
2002
|
|
3 |
p. 215-215
|
artikel
|
| 5 |
A prospective study to investigate the incidence of atherosclerotic vascular disease in patients with newly diagnosed type 2 diabetes mellitus
|
Doyle, Arthur
|
|
2005
|
|
3 |
p. 155-158
|
artikel
|
| 6 |
A retrospective review of the management of asymptomatic retinal emboli identified during diabetic retinopathy screening: a case of inappropriate referral?
|
Wilde, Craig
|
|
2010
|
|
3 |
p. 126-129
|
artikel
|
| 7 |
ASCOT — lipid lowering arm
|
Kirby, Mike
|
|
2003
|
|
3 |
p. 200-201
|
artikel
|
| 8 |
Aspects of drug development and clinical trials — Part 1
|
Matfin, Glenn
|
|
2007
|
|
3 |
p. 97-98
|
artikel
|
| 9 |
Assessing the risk of cardiovascular disease in patients with type 2 diabetes
|
Mead, Mike
|
|
2002
|
|
3 |
p. 191-194
|
artikel
|
| 10 |
Association between circulating endothelial progenitor cells and hs-CRP in patients with diabetes
|
Koshikawa, Megumi
|
|
2010
|
|
3 |
p. 133-138
|
artikel
|
| 11 |
Auto-ophthalmoscopy: a novel way to practice retinal examination
|
Armour, Roger H
|
|
2005
|
|
3 |
p. 142-144
|
artikel
|
| 12 |
Bariatric surgery for diabetes: gastric banding is simple and safe
|
Pinkney, Jonathan
|
|
2010
|
|
3 |
p. 139-142
|
artikel
|
| 13 |
Beyond LDL lowering: the role of dyslipidaemia and inflammation
|
Feher, Michael D
|
|
2003
|
|
3 |
p. 157-159
|
artikel
|
| 14 |
Blood pressure measurement in the clinic and at home
|
Addison, Clare
|
|
2002
|
|
3 |
p. 189-190
|
artikel
|
| 15 |
Cardiovascular disease in type 2 diabetes: targets, risks and patients
|
Taylor, Ken
|
|
2002
|
|
3 |
p. 195-197
|
artikel
|
| 16 |
Cascade screening for familial hypercholesterolaemia in Scotland
|
Finnie, Robert M
|
|
2010
|
|
3 |
p. 123-125
|
artikel
|
| 17 |
Changes in diabetic retinopathy noticed after chemotherapy for duodenal carcinoma
|
Varughese, George
|
|
2004
|
|
3 |
p. 206-208
|
artikel
|
| 18 |
Clinical aspects of silent myocardial ischaemia: with particular reference to diabetes mellitus
|
Dweck, Marc
|
|
2009
|
|
3 |
p. 110-116
|
artikel
|
| 19 |
Clinical trials of lipid-lowering medication in diabetes
|
Durrington, Paul
|
|
2003
|
|
3 |
p. 217-220
|
artikel
|
| 20 |
Cognitive decline: the relevance of diabetes, hyperlipidaemia and hypertension
|
Etgen, Thorleif
|
|
2010
|
|
3 |
p. 115-122
|
artikel
|
| 21 |
Collaboration between hospital and primary care can improve the management of diabetic nephropathy
|
Thomas, Nicola
|
|
2004
|
|
3 |
p. 202-204
|
artikel
|
| 22 |
Commonly asked questions
|
Feher, Michael D
|
|
2003
|
|
3 |
p. 202-203
|
artikel
|
| 23 |
Comparison of the effects of long-term pioglitazone and rosiglitazone therapy on liver enzymes in type 2 diabetes
|
Phey Ming Yeap,
|
|
2011
|
|
3 |
p. 121-129
|
artikel
|
| 24 |
Comparison of the postprandial glucose and insulin profiles with nateglinide and gliclazide in type 2 diabetic patients
|
Schweizer, Anja
|
|
2002
|
|
3 |
p. 228-232
|
artikel
|
| 25 |
Comparison of three different definitions for the metabolic syndrome in non-diabetic Europeans
|
Qiao, Qing
|
|
2005
|
|
3 |
p. 161-168
|
artikel
|
| 26 |
Considering Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial
|
Redpath, Calum J
|
|
2002
|
|
3 |
p. 187-188
|
artikel
|
| 27 |
DAIS: how it relates to other lipid intervention studies in diabetes
|
Steiner, George
|
|
2003
|
|
3 |
p. 212-215
|
artikel
|
| 28 |
Development of new onset and extensive xanthelasma in HIV hyperlipidaemia
|
Park, Adrian J
|
|
2008
|
|
3 |
p. 149-150
|
artikel
|
| 29 |
Diabetes and coronary artery disease in South Asians
|
Swaminathan, Krishnan
|
|
2013
|
|
3 |
p. 124-129
|
artikel
|
| 30 |
Diabetes and embryonic stem cells: a guide to the ethical debate
|
Kirklin, Deborah
|
|
2002
|
|
3 |
p. 198-201
|
artikel
|
| 31 |
Diabetes and frailty: an emerging issue. Part 2: Linking factors
|
Atiénzar, Pilar
|
|
2012
|
|
3 |
p. 119-122
|
artikel
|
| 32 |
Diabetes and frailty: an emerging issue. Part 1: Sarcopaenia and factors affecting lower limb function
|
Atiénzar, Pilar
|
|
2012
|
|
3 |
p. 110-116
|
artikel
|
| 33 |
Diabetes care in the Sikh patient: cultural and clinical aspects
|
Goenka, Nirupam
|
|
2002
|
|
3 |
p. 202-205
|
artikel
|
| 34 |
Diabetes, disability and frailty – a need for greater recognition and focused research
|
Sinclair, Alan J
|
|
2012
|
|
3 |
p. 109-109
|
artikel
|
| 35 |
Diabetes Endocrinology in Medical Education (DEME) Survey - an evaluation of diabetes and endocrinology teaching at a UK medical school
|
Jose, Biju
|
|
2012
|
|
3 |
p. 153-154
|
artikel
|
| 36 |
Diabetes information technology in UK diabetes secondary care: a snapshot
|
Parker, Vicki ER
|
|
2013
|
|
3 |
p. 150-154
|
artikel
|
| 37 |
Diabetes P4P: a view from near and far
|
Matfin, Glenn
|
|
2009
|
|
3 |
p. 96-97
|
artikel
|
| 38 |
Diabetes treatments, gastrointestinal symptoms and lower gastrointestinal endoscopy
|
Kent, Alex J
|
|
2009
|
|
3 |
p. 129-130
|
artikel
|
| 39 |
Diabetic papillopathy diagnosed on retinal screening in an asymptomatic patient
|
Zachariah, Sunil
|
|
2007
|
|
3 |
p. 140-141
|
artikel
|
| 40 |
Diagnostic definitions — metabolic syndrome
|
Day, Caroline
|
|
2005
|
|
3 |
p. 115-118
|
artikel
|
| 41 |
Disability in older people with diabetes: issues for the clinician
|
Bourdel-Marchasson, Isabelle
|
|
2012
|
|
3 |
p. 135-140
|
artikel
|
| 42 |
Diversity and complexity of urinary tract infection in diabetes mellitus
|
Hakeem, Lukman M
|
|
2009
|
|
3 |
p. 119-125
|
artikel
|
| 43 |
Dyslipidaemia in type 2 diabetes: epidemiology and biochemistry
|
Valabhji, Jonathan
|
|
2003
|
|
3 |
p. 184-189
|
artikel
|
| 44 |
Early-onset type 2 diabetes: not a benign condition
|
Song, Soon H
|
|
2009
|
|
3 |
p. 137-138
|
artikel
|
| 45 |
Emphysematous pyelonephritis: a rare but potentially life-threatening complication of poorly controlled diabetes
|
Pojak, Katie
|
|
2013
|
|
3 |
p. 155-157
|
artikel
|
| 46 |
Erratum
|
|
|
2009
|
|
3 |
p. 97-97
|
artikel
|
| 47 |
Familial dysbetalipoproteinaemia, chronic inflammatory arthropathy and diabetes mellitus causing premature peripheral vascular atherosclerosis
|
Van Heyningen, Charles
|
|
2010
|
|
3 |
p. 153-154
|
artikel
|
| 48 |
Familial hypercholesterolaemia and dyslipidaemias: new international guidelines for clinical practice
|
Sell, Craig
|
|
2012
|
|
3 |
p. 130-134
|
artikel
|
| 49 |
Fluid management in diabetic ketoacidosis: are we adhering to recommended guidelines?
|
Freudenthal, Robert
|
|
2013
|
|
3 |
p. 138-142
|
artikel
|
| 50 |
Foot guide
|
Day, Caroline
|
|
2006
|
|
3 |
p. 139-140
|
artikel
|
| 51 |
Gabapentin for the treatment of painful diabetic neuropathy: dosing to achieve optimal clinical response
|
Gómez-Pérez, Francisco J
|
|
2004
|
|
3 |
p. 173-178
|
artikel
|
| 52 |
Goodbye glitazars?
|
Conlon, Deane
|
|
2006
|
|
3 |
p. 135-137
|
artikel
|
| 53 |
Haemoglobin response to intravenous iron in non-dialysis patients with chronic kidney disease and diabetes
|
Mostafa, Samiul A
|
|
2009
|
|
3 |
p. 126-128
|
artikel
|
| 54 |
HbA1c - changing units
|
Day, Caroline
|
|
2009
|
|
3 |
p. 134-136
|
artikel
|
| 55 |
HbA1c: changing units, changing minds – mission accomplished?
|
Levy, David
|
|
2013
|
|
3 |
p. 111-114
|
artikel
|
| 56 |
Highlights from the Fifth International Symposium on Diabetes and Pregnancy
|
Duncan, Catriona
|
|
2009
|
|
3 |
p. 139-140
|
artikel
|
| 57 |
HIV-associated lipodystrophy - a new metabolic syndrome
|
Hakeem, Lukman
|
|
2008
|
|
3 |
p. 129-134
|
artikel
|
| 58 |
Hypertriglyceridaemia-induced acute pancreatitis in the third trimester of pregnancy
|
Ln Rao Bondugulapati,
|
|
2011
|
|
3 |
p. 155-156
|
artikel
|
| 59 |
Hypertriglyceridaemia, LPL deficiency and pancreatitis -pathogenesis and therapeutic options
|
Munigoti, Srinivasa P
|
|
2011
|
|
3 |
p. 107-112
|
artikel
|
| 60 |
Impaired glucose tolerance and metformin: clinical and mechanistic aspects
|
Hermann, Leif Sparre
|
|
2002
|
|
3 |
p. 177-183
|
artikel
|
| 61 |
Increasing choice to treat obesity
|
Bailey, Clifford J
|
|
2006
|
|
3 |
p. 101-101
|
artikel
|
| 62 |
Inpatient management of patients with diabetes and chronic kidney disease undergoing elective surgery in a large nephrology centre
|
Suckling, Rebecca J
|
|
2012
|
|
3 |
p. 123-127
|
artikel
|
| 63 |
Insulin glargine plus oral antidiabetic agents in comparison with biphasic insulin in type 2 diabetes: a UK cost comparison
|
Owens, David
|
|
2011
|
|
3 |
p. 141-144
|
artikel
|
| 64 |
Insulin resistance and novel markers of cardiovascular disease in 2 diabetes cardiovascular disease in type 2 diabetes
|
|
|
2002
|
|
3 |
p. 1-S5
|
artikel
|
| 65 |
Intentional and unintentional non-adherence in community dwelling people with type 2 diabetes: the effect of varying numbers of medicines
|
Stack, Rebecca J
|
|
2010
|
|
3 |
p. 148-152
|
artikel
|
| 66 |
International Charter of Rights and Responsibilities of People with Diabetes
|
Wientjens, Wim H.J.M.
|
|
2011
|
|
3 |
p. 105-106
|
artikel
|
| 67 |
Is non-dipping of nocturnal blood pressure in type 2 diabetes associated with increased incidence of microalbuminuria?
|
Heggie, Alison J
|
|
2008
|
|
3 |
p. 136-139
|
artikel
|
| 68 |
Lack of association between early atherosclerotic carotid artery wall lesions and serum level of homocysteine
|
Rajala, Ulla
|
|
2003
|
|
3 |
p. 230-232
|
artikel
|
| 69 |
Metformin: a practical guide to optimising outcomes
|
|
|
2008
|
|
3 |
p. 153-156
|
artikel
|
| 70 |
Monotherapy with metformin or glimepiride and changes in serum sialic acid in type 2 diabetes mellitus
|
Inayat Ur Rahman,
|
|
2011
|
|
3 |
p. 137-140
|
artikel
|
| 71 |
My Diabetes My Way: an electronic personal health record for diabetes
|
Cunningham, Scott G
|
|
2013
|
|
3 |
p. 143-149
|
artikel
|
| 72 |
NAUTILUS (Safety and tolerability of Niaspan®): a subgroup analysis in patients with diabetes
|
Vogt, Anja
|
|
2006
|
|
3 |
p. 127-133
|
artikel
|
| 73 |
New guidance on diabetes prevention: will it make a difference?
|
Greaves, Colin J
|
|
2010
|
|
3 |
p. 105-106
|
artikel
|
| 74 |
NICE guidelines for management of lipids in type 2 diabetes mellitus: a practical interpretation
|
Samarasinghe, Yohan
|
|
2003
|
|
3 |
p. 222-225
|
artikel
|
| 75 |
Patient preferences for diabetes care
|
Galliford, Thomas M
|
|
2010
|
|
3 |
p. 130-132
|
artikel
|
| 76 |
Pharmacological management of hyperlipidaemia
|
Evans, Marc
|
|
2003
|
|
3 |
p. 204-210
|
artikel
|
| 77 |
Pioglitazone: an agent which reduces stroke, myocardial infarction and death and is also a key component of the modern paradigm for the optimum management of type 2 diabetes
|
Ryder, R.E.J.
|
|
2011
|
|
3 |
p. 113-120
|
artikel
|
| 78 |
Polypharmacy and renal failure
|
Shaafi, Khalifa
|
|
2011
|
|
3 |
p. 150-152
|
artikel
|
| 79 |
Predictors of mortality in patients with peripheral vascular disease. A prospective follow-up study
|
Missouris, Constantinos G
|
|
2004
|
|
3 |
p. 196-200
|
artikel
|
| 80 |
Promoting physical activity in people with type 2 diabetes
|
Kirk, Alison
|
|
2002
|
|
3 |
p. 211-213
|
artikel
|
| 81 |
Real time continuous glucose monitoring: how does it work in real life?
|
Geelhoed-Duijvestijn, Petronella H.
|
|
2011
|
|
3 |
p. 145-149
|
artikel
|
| 82 |
Retinopathy in prediabetes
|
Ghosh, Sujoy
|
|
2010
|
|
3 |
p. 155-156
|
artikel
|
| 83 |
Review: Bariatric surgery: to treat diabesity
|
Flatt, Peter R
|
|
2009
|
|
3 |
p. 103-107
|
artikel
|
| 84 |
Review: Biomarkers in clinical trials and drug development: measurement of cardiometabolic risk
|
Matfin, Glenn
|
|
2007
|
|
3 |
p. 101-106
|
artikel
|
| 85 |
Review: Clinical aspects of the management of HIV lipodystrophy
|
Wierzbicki, Anthony S
|
|
2008
|
|
3 |
p. 113-119
|
artikel
|
| 86 |
Review: Comparing cardiovascular outcomes in diabetes studies
|
Mccallum, Roland W
|
|
2006
|
|
3 |
p. 111-118
|
artikel
|
| 87 |
Review: Development and therapeutic potential of incretin hormone analogues for type 2 diabetes
|
Green, Brian D
|
|
2005
|
|
3 |
p. 134-140
|
artikel
|
| 88 |
Review: Diabetes and the QT interval: time for debate
|
Kumar, Rajeev
|
|
2004
|
|
3 |
p. 146-150
|
artikel
|
| 89 |
Review: Drug treatments for obesity: where are we heading and how do we get there?
|
Sonnenberg, Gabriele E
|
|
2007
|
|
3 |
p. 111-117
|
artikel
|
| 90 |
Review: Ezetimibe — clinical and pharmacological profile
|
Rees, Alan
|
|
2004
|
|
3 |
p. 163-171
|
artikel
|
| 91 |
Review: Inhaled insulin: overcoming barriers to insulin therapy?
|
Bellary, Srikanth
|
|
2006
|
|
3 |
p. 103-108
|
artikel
|
| 92 |
Review: Lipid lowering drugs, inflammation and cardiovascular disease
|
Schachter, Michael
|
|
2003
|
|
3 |
p. 178-182
|
artikel
|
| 93 |
Review: Lipids and stroke
|
Buckley, Brendan M
|
|
2003
|
|
3 |
p. 170-176
|
artikel
|
| 94 |
Review: Managing the diabetic patient with angina
|
Foo, Kong
|
|
2002
|
|
3 |
p. 169-175
|
artikel
|
| 95 |
Review: Mechanisms of silent myocardial ischaemia: with particular reference to diabetes mellitus
|
Dweck, Marc
|
|
2009
|
|
3 |
p. 99-102
|
artikel
|
| 96 |
Review: Pharmacological approaches to reduce adiposity
|
Day, Caroline
|
|
2006
|
|
3 |
p. 121-125
|
artikel
|
| 97 |
Review: Pre-diabetes: clinical relevance and therapeutic approach
|
Pratley, Richard E
|
|
2007
|
|
3 |
p. 120-129
|
artikel
|
| 98 |
Review: Reconsidering the value of fibrates: lessons from the trials
|
Barter, Philip
|
|
2003
|
|
3 |
p. 162-167
|
artikel
|
| 99 |
Review: Renal dysfunction as a marker of increased vascular risk
|
Andrews, Peter
|
|
2004
|
|
3 |
p. 152-155
|
artikel
|
| 100 |
Review: Risk factor assessment of erectile dysfunction
|
Hood, Stuart
|
|
2004
|
|
3 |
p. 157-161
|
artikel
|
| 101 |
Review: The endocannabinoid system: a new therapeutic target for cardiovascular risk factor management
|
Finer, Nick
|
|
2005
|
|
3 |
p. 121-124
|
artikel
|
| 102 |
Review: The management of tibial artery disease in diabetes
|
Torella, Francesco
|
|
2002
|
|
3 |
p. 162-166
|
artikel
|
| 103 |
Review: The role of omega-3 fatty acids in cardiovascular disease, hypertriglyceridaemia and diabetes mellitus
|
Kandasamy, Narayanan
|
|
2008
|
|
3 |
p. 121-126
|
artikel
|
| 104 |
Review: Vascular protective effects of peroxisome proliferator-activated receptor agonists
|
Cariou, Bertrand
|
|
2005
|
|
3 |
p. 126-132
|
artikel
|
| 105 |
Review: Which patients with diabetes should receive which antiplatelet agents?
|
Lowe, Gordon
|
|
2002
|
|
3 |
p. 157-160
|
artikel
|
| 106 |
Role of laparoscopic adjustable gastric banding in the treatment of obesity and related disorders
|
Singhal, Rishi
|
|
2009
|
|
3 |
p. 131-133
|
artikel
|
| 107 |
Role of maternal vitamin B12 on the metabolic health of the offspring: a contributor to the diabetes epidemic?
|
Saravanan, Ponnusamy
|
|
2010
|
|
3 |
p. 109-114
|
artikel
|
| 108 |
Screening for diabetes and cardiometabolic disease in women with polycystic ovary syndrome
|
Tomlinson, Julie A
|
|
2013
|
|
3 |
p. 115-123
|
artikel
|
| 109 |
Screening patients with ischaemic heart disease and hypertension for undiagnosed diabetes
|
Savage, George
|
|
2002
|
|
3 |
p. 224-227
|
artikel
|
| 110 |
Severe hypertriglyceridaemia with splenomegaly in type 2 diabetes
|
Mcdougall, Claire
|
|
2003
|
|
3 |
p. 227-228
|
artikel
|
| 111 |
Sitagliptin — enhancing incretin action
|
Campbell, Ian W
|
|
2007
|
|
3 |
p. 134-139
|
artikel
|
| 112 |
Socioeconomic status, cardiovascular risk factors and the incidence of microvascular and macrovascular disease in type 1 diabetes
|
Swaminathan, Krishnan
|
|
2004
|
|
3 |
p. 180-188
|
artikel
|
| 113 |
`Sociotype': a key determinant of diabetes health
|
Connolly, Vincent
|
|
2004
|
|
3 |
p. 141-144
|
artikel
|
| 114 |
Surgical interventions to correct metabolic disorders
|
Lahsen, Rodolfo
|
|
2010
|
|
3 |
p. 143-147
|
artikel
|
| 115 |
The ageing pancreas
|
Brown, James E
|
|
2012
|
|
3 |
p. 141-145
|
artikel
|
| 116 |
The Glasgow Chart — a simple method for calculation of cardiovascular risk in type 2 diabetes
|
Mcintyre, Martin
|
|
2002
|
|
3 |
p. 208-210
|
artikel
|
| 117 |
The MERCURY I open-label extension study — subgroup analysis in patients with diabetes
|
Schuster, Herbert
|
|
2008
|
|
3 |
p. 142-147
|
artikel
|
| 118 |
The outcome of total hip arthroplasty in diabetes mellitus
|
Chan, Peter Kh
|
|
2005
|
|
3 |
p. 146-149
|
artikel
|
| 119 |
The relationship between dopamine and renalase in type 2 diabetic patients with and without diabetic nephropathy
|
Gaber, Eman W
|
|
2013
|
|
3 |
p. 130-137
|
artikel
|
| 120 |
The responses of the iliac artery to insulin: direct delayed nitric oxide-mediated dilatation
|
O'Hora, Therese Ruane
|
|
2011
|
|
3 |
p. 130-136
|
artikel
|
| 121 |
The use of plasmapheresis in managing primary biliary cirrhosis presenting with profound hypercholesterolaemia
|
Wong, Mo Lee
|
|
2012
|
|
3 |
p. 156-158
|
artikel
|
| 122 |
Ulnar mononeuropathy in diabetes mellitus
|
Wake, Deborah J
|
|
2005
|
|
3 |
p. 171-172
|
artikel
|
| 123 |
Voodoo medicine — cardiovascular trials jinxed in New Orleans
|
Wierzbicki, Anthony S
|
|
2007
|
|
3 |
p. 142-144
|
artikel
|
| 124 |
What are the clinical manifestations of cardiovascular disease in diabetes? Ten year analysis from a clinic based population
|
Stephens, Jeffrey W
|
|
2004
|
|
3 |
p. 190-194
|
artikel
|
| 125 |
When and how to measure lipids and their role in CHD risk prediction
|
Richmond, William
|
|
2003
|
|
3 |
p. 191-198
|
artikel
|
| 126 |
Why we need a new model for diabetes care
|
Matthews, David R
|
|
2007
|
|
3 |
p. 130-131
|
artikel
|
| 127 |
Will the NICE guidelines on diabetes in pregnancy improve outcomes?
|
Dornhorst, Anne
|
|
2008
|
|
3 |
p. 107-110
|
artikel
|
Tijdschrift beschrijving